Together, EGFR, GRIN2B, GJA1, CAP2, MIF, POLR2A, PRKACA, GABARAP, TLN1 and PXN might be effective targets in T1D, but more experimental investigations and clinical trials are needed. The gene discussed is PRKACA; the disease is type 1 diabetes mellitus.